首页> 外文OA文献 >Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs
【2h】

Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs

机译:在中孔碳酸镁Upsalite中稳定无定形布洛芬,以增加难溶性药物的水溶性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

One attractive approach to increase the aqueous solubility and thus the bioavailability of poorly soluble drugs is to formulate them in their amorphous state since amorphous compounds generally exhibit higher apparent solubilities than their crystalline counterparts. In the current work, mesoporous magnesium carbonate was used to stabilise the amorphous state of the model substance ibuprofen. Crystallisation of the drug was completely supressed in the formulation, resulting in both a higher apparent solubility and a three times faster dissolution rate of the drug where the drug release was shown to be diffusion controlled. It was also shown that the formulation is stable for at least three months when stored at 75% relative humidity. The simple synthesis together with a high loading capacity and narrow pore size distribution of the mesoporous magnesium carbonate is foreseen to offer great advantages in formulations of poorly soluble drugs.
机译:一种增加水溶性和因此难溶性药物的生物利用度的有吸引力的方法是将它们配制成无定形状态,因为无定形化合物通常比其结晶对应物具有更高的表观溶解度。在目前的工作中,使用中孔碳酸镁来稳定模型物质布洛芬的非晶态。在制剂中完全抑制了药物的结晶,这导致了较高的表观溶解度和三倍更快的药物溶解速度,其中药物的释放被证明是受扩散控制的。还表明,当在75%相对湿度下储存时,该制剂稳定至少三个月。预计简单的合成以及介孔碳酸镁的高负载量和狭窄的孔径分布在难溶性药物制剂中将提供巨大的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号